Share Your Experience with LGS and Dravet Syndrome

Related Articles

An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies

Developmental and epileptic encephalopathies (DEEs) are complex conditions characterized primarily by seizures associated with neurodevelopmental and motor deficits. Recent evidence supports sigma-1 receptor modulation in both neuroprotection and antiseizure activity, suggesting that sigma-1 receptors may play a role in the pathogenesis of DEEs, and that targeting this receptor has the potential to positively impact both seizures and non-seizure outcomes in these disorders.

August 2021

Read more

Dravet Syndrome

This review will illustrate the electroclinical description of Dravet syndrome, highlighting the difficulty to understand the correlation between the SCN1A mutation and clinical characteristics, including the frequent comorbidities.

April 2021

Read more

Dravet syndrome: A quick transition guide for the adult neurologist

Dravet syndrome (DS) is still seen as a "pediatric disease", where patients receive excellent care in pediatric centers, but care is less than optimal in adult health care systems (HCS). This creates a barrier when young adults need to leave the family-centered pediatric system and enter the adult, patient-centered HCS. Here we create a guide to help with the transition from pediatric to adult for patients with DS.

June 2021

Read more

New and emerging pharmacologic treatments for developmental and epileptic encephalopathies

Lennox Gastaut Syndrome (LGS) is an age related, epileptic encephalopathy of varied etiology. The syndrome is characterized by multiple seizure types, intellectual failure and/or behavioural disturbance and by EEG abnormalities. ADHD and epilepsy are both common childhood disorders and can have negative consequences on child’s health.

April 2022

Read more

Tonic Seizures in a Patient With Lennox–Gastaut Syndrome Manifest as “Icicles” Rather Than “Flames” on Quantitative EEG Analysis

Quantitative analysis of continuous electroencephalography (QEEG) is increasingly being used to augment seizure detection in critically ill patients. Typically, seizures manifest on QEEG as abrupt increases in power and frequency, a visual pattern often called "flames."

February 2023

Read more

About LGS and Dravet Syndrome

From Merritt’s Neurology, 14th edition:

Lennox-Gastaut Syndrome

The term Lennox-Gastaut syndrome (LGS) is often improperly used as a synonym for symptomatic generalized epilepsy, but like other age-dependent epileptic encephalopathies, such as West syndrome, LGS is defined by the presence of specific seizure types and EEG features. The etiology is variable. LGS can occur in the context of acquired brain injury, pathogenic genetic variants, and/or MCD. Age of onset is between 3 and 5 years of age. The core seizure types include tonic seizures (the hallmark of LGS), especially arising out of sleep, atonic seizures (drop attacks), and atypical absences. The EEG is poorly organized and shows diffuse, usually frontally predominant, slow (2-2.5 Hz) spike and wave during wakefulness and bursts of generalized paroxysmal fast activity during non–rapid eye movement sleep. Ictal EEG of the atypical absences is characterized by a prolonged runs of the slow spike-and-wave complex described earlier. Atonic seizures associated with a generalized spike- or polyspike-wave and tonic seizures manifest with diffuse fast activity (10-20 Hz) accompanying electrodecrement. In patients who evolve to LGS from WS (approximately 20% of LGS), the tonic component and corresponding electrodecrement of epileptic spasms may become progressively prolonged, morphing into tonic seizures over time.

Dravet Syndrome

Variants in SCN1A were originally identified in genetic epilepsy with febrile seizures plus families, but SCN1A was subsequently discovered to be the major gene for Dravet syndrome (DS), accounting for >85% of cases. SCN1A encodes a voltage-gated sodium channel important for inhibitory interneuron function. DS has an onset between 3 and 8 months (peak at 6 mo) and presents with bouts of status epilepticus with hemiclonic or generalized clonic or tonic-clonic seizures most often triggered by increased temperature. Typically, even a mild increase in body temperature due to fever, hot weather, or hot bath can be a triggering factor. These episodes become frequent over time and, between 1 and 4 years, other seizure types appear, including myoclonic jerks, atypical absences, and focal impaired awareness seizures. The EEG is usually normal at onset but progresses to generalized, focal, and multifocal abnormalities. Photosensitivity is present early in approximately 40% of patients. The occurrence of sudden unexplained death in epilepsy is relatively high. From the second year of life, children demonstrate variable neurologic impairment, such as ataxia and corticospinal tract dysfunction, as well as behavioral disturbances, and learning disabilities. Seizure frequency tends to stabilize or decrease after 5 years, but developmental outcomes remain severe.